These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1471601)

  • 61. Summary of U.S. clinical trials program for evaluation of anistreplase.
    Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Which thrombolytic agents as therapy in acute myocardial infarct?].
    Strauer BE
    Med Klin (Munich); 1992 Feb; 87(2):81-2. PubMed ID: 1542287
    [No Abstract]   [Full Text] [Related]  

  • 63. Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).
    Taeymans Y; Materne P
    Drugs; 1987; 33 Suppl 3():216-20. PubMed ID: 3315594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
    Brügemann J; van der Meer J; Takens BH; Hillege H; Lie KI
    Br Heart J; 1990 Dec; 64(6):355-8. PubMed ID: 2271340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
    Julian DG; Borthwick LS; Reid D; Jennings KP; Wainwright RJ; Rodger JC; Wood D; Phillips WS
    Drugs; 1987; 33 Suppl 3():261-7. PubMed ID: 3315604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacology of anistreplase.
    Sherry S
    Clin Cardiol; 1990 Mar; Suppl 5():V3-10; discussion V27-32. PubMed ID: 2182238
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ
    J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
    Rapold HJ
    Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Are the various thrombolytic agents equally effective in the treatment of acute transmural myocardial infarction?
    Claessens J; Haseldonckx C
    Jpn Heart J; 1992 Jul; 33(4):413-21. PubMed ID: 1453546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
    Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Piana RN; Breall JA; Sharaf B; Flatley M; Alexander B; Diver DJ; McCabe CH; Flaker GC
    J Am Coll Cardiol; 1995 Mar; 25(3):582-9. PubMed ID: 7860900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of perfusion data.
    Rapaport E
    Eur Heart J; 1990 Aug; 11 Suppl F():10-4. PubMed ID: 2121487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thrombolytics.
    Ostrow CL
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):423-36. PubMed ID: 1576039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction.
    Granger CB; White HD; Bates ER; Ohman EM; Califf RM
    Am J Cardiol; 1994 Dec; 74(12):1220-8. PubMed ID: 7977094
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thrombolytic therapy: then and now.
    Cole PL
    Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Angiographic assessment of patency and reocclusion: preliminary results of the Dutch APSAC Reocclusion Multicenter Study (ARMS).
    Visser RF
    Clin Cardiol; 1990 Mar; Suppl 5():V45-7; discussion V67-72. PubMed ID: 2182241
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thrombolytic therapy.
    Collen D; Stump DC; Gold HK
    Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin.
    Croydon EA
    Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
    Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
    Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.